Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics Announces Late-Breaking Presentation at 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress
07:00am, Wednesday, 29'th Sep 2021
Results from KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus to be presented Results from KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatiti
Cara Therapeutics to Present at the the 2021 Cantor Virtual Global Healthcare Conference
07:00am, Friday, 24'th Sep 2021
STAMFORD, Conn., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to all
Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval
08:55am, Saturday, 04'th Sep 2021
There's good news at long last for the beaten-down biotech stock.
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
02:00pm, Tuesday, 31'st Aug 2021
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New molecular entity approvals
Why Cara Therapeutics Shot Higher Today
04:08pm, Tuesday, 24'th Aug 2021
The biotech gets an important nod from a top regulator.
CARA Stock: The Huge FDA News Sending Cara Therapeutics Skyrocketing Today
03:43pm, Tuesday, 24'th Aug 2021
Shares of CARA stock are ticking higher on Tuesday after the Cara Therapeutics' injection treatment was approved by the FDA. The post CARA Stock: The Huge FDA News Sending Cara Therapeutics Skyrocketi
Biotech Stock Takes on Technical Ceiling After FDA Okay
02:13pm, Tuesday, 24'th Aug 2021
Care Therapeutics Inc (NASDAQ:CARA) is seeing a influx of options activity today, following news that the U.S. Food and Drug Administration (FDA) approved its Korsuva difelikefalin injection to treat
CARA Drug Wins FDA Nod for Pruritus Associated With CKD
12:59pm, Tuesday, 24'th Aug 2021
CARA gets a significant boost with FDA approval for Korsuva injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.
Why Is Cara Therapeutics Stock Trading Higher Today?
10:57am, Tuesday, 24'th Aug 2021
Cara Therapeutics Inc (NASDAQ: CARA) is trading higher Tuesday after the company, and Vifor Pharma, announced the U.S. Food and Drug Administration approved KORSUVA for injection for the treatment
See Why Cara Therapeutics (CARA) Stock Is Moving Higher On Tuesday
07:40am, Tuesday, 24'th Aug 2021
The FDA has approved Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma AG's Korsuva (difelikefalin) injection for severe-to-moderate pruritis (itching) in patients with chronic kidney disease
Cara Therapeutics Shares Increase Over 20% Pre-Market: Why It Happened
07:05am, Tuesday, 24'th Aug 2021
The shares of Cara Therapeutics Inc (NASDAQ: CARA) increased by over 20% pre-market. This is why it happened.
ST. GALLEN, Switzerland & STAMFORD, Conn.--(BUSINESS WIRE)--Regulatory News: Vifor Pharma and Cara Therapeutics (Nasdaq:CARA) today announced that the U.S. Food and Drug Administration (FDA) has appr
These 2 Stocks Just Soared After Hours Monday
07:06pm, Monday, 23'rd Aug 2021
After a record-setting day, the news for these two companies was icing on the cake.
STAMFORD, Conn. and ST. GALLEN, Switzerland, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has a
Is the Options Market Predicting a Spike in Cara Therapeutics (CARA) Stock?
11:47am, Wednesday, 11'th Aug 2021
Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.
